# Early Administration of Ivabradine in Children With Heart Failure

> **NCT04405804** · PHASE2 · UNKNOWN · sponsor: **Bambino Gesù Hospital and Research Institute** · enrollment: 9 (estimated)

## Conditions studied

- Acute Heart Failure
- Dilated Cardiomyopathy

## Interventions

- **DRUG:** Ivabradine 5Mg Tab

## Key facts

- **NCT ID:** NCT04405804
- **Lead sponsor:** Bambino Gesù Hospital and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-20
- **Primary completion:** 2021-01
- **Final completion:** 2021-05
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2020-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405804, "Early Administration of Ivabradine in Children With Heart Failure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04405804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*